NCT00271817
To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)
See it on ClinicalTrials.gov ↗1,220 people
49.8%
50.2%
608 womenmiddle line = equal numbers612 men
- Phase
- PHASE3
- Paid for by
- Organon and Co
- Finished
- 2008-02
- Health conditions
- Hypercholesterolemia
- Who could join
- Anyone
- Ages
- 18 Years – 79 Years
- Average age
- mean 56.9 years
- Age 65+
- Not reported
- Weight (BMI)
- mean 222 Participants
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 85.8% · Hispanic / Latina 6.1% · Black / African American 5.6% · Asian 2.1% · Other 0.4%
Women left out
- No pregnant women
Women who were pregnant could not join.
“Pregnant or lactating women or intending to become pregnant”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Pregnant or lactating women or intending to become pregnant”
Study titles and rules are shown in their original English.